Skip to content
healthcare.dev

Abiraterone Acetate

NDC 60219-1165, Abiraterone, tablet, from Amneal Pharmaceuticals LLC.

Product NDC
60219-1165
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208327
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60219-1165 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABIRATERONE ACETATE250 mg/1

Pharmacologic classes

Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]

Package NDCNDC-11Package
60219-1165-760219116507120 TABLET in 1 BOTTLE (60219-1165-7)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6fda6b92-59ed-4180-af68-94052a5e82cf
  • NADAC price for package 60219116507

    GET /v1/drugs/nadac/60219116507

Use it

Look up 60219-1165 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60219-1165 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60219-1165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.